Roche, Novartis, Genentech fined EUR444 million in France for collective dominance abuse
Roche, Novartis and Genentech were today fined for abusing a position of collective dominance in France to hinder the entry of a cheap drug for age-related macular degeneration. Roche, Novartis and Genentech...To view the full article, register now.
Already a subscriber? Click here to view full article